AG
Amita Garg
About Amita Garg
Data last updated:
Amita Garg is a Director at Q-Line Biotech Limited (since 2010), Director at Heidelco Medicore Private Limited (since 2016) and Director at Asg Buildtech Private Limited (since 2018), and holds 4 more current directorships. The companies operate in Healthcare, Real Estate and Construction and Education. The 6 current companies with reported revenue have a combined latest revenue of ₹374 Cr; the largest is Q-Line Biotech Limited at ₹322 Cr (FY 2025). Earlier, Amita Garg was a Director at Poct Science House Private Limited (2020–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Nov 2010 | 2010 | ₹322 Cr (FY 2025) | Active | |
| Director | 10 Feb 2016 | 2013 | ₹51.23 Cr (FY 2024) | Active | |
| Director | 12 Jan 2018 | 2018 | ₹1.12 Cr (FY 2025) | Active | |
| Director | 01 Oct 2021 | 1988 | ₹8.2 Lakh (FY 2025) | Active | |
| Director | 21 Mar 2018 | 2018 | ₹4.2 Lakh (FY 2024) | Active | |
| Director | 19 Dec 2022 | 2022 | ₹15,562 (FY 2023) | Active | |
| Director | 07 Dec 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Nov 2020 | 2019 | ₹132 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Amita Garg
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amita Garg
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amita Garg
Amita Garg currently holds 7 directorships: Q-Line Biotech Limited (Director, since 10 Nov 2010, revenue ₹322 Cr (FY 2025)); Heidelco Medicore Private Limited (Director, since 10 Feb 2016, revenue ₹51.23 Cr (FY 2024)); Asg Buildtech Private Limited (Director, since 12 Jan 2018, revenue ₹1.12 Cr (FY 2025)); Q-Line Healthcare Private Limited (Director, since 01 Oct 2021, revenue ₹8.2 Lakh (FY 2025)); Poct Quality & Skill Development Foundation (Director, since 21 Mar 2018, revenue ₹4.2 Lakh (FY 2024)); and 2 more.
Amita Garg was first appointed on 10 Nov 2010 as Director at Q-Line Biotech Limited. The most recent appointment on record is 07 Dec 2023 at Q-Line Iris Private Limited.
The 6 current companies of Amita Garg that report revenue have a combined latest revenue of ₹374 Cr: Q-Line Biotech Limited ₹322 Cr (FY 2025); Heidelco Medicore Private Limited ₹51.23 Cr (FY 2024); Asg Buildtech Private Limited ₹1.12 Cr (FY 2025); Q-Line Healthcare Private Limited ₹8.2 Lakh (FY 2025); Poct Quality & Skill Development Foundation ₹4.2 Lakh (FY 2024); and 1 more.
Amita Garg held 1 earlier board appointment: Poct Science House Private Limited (Director, 19 Nov 2020 to 15 Mar 2025).
The current boards of Amita Garg's companies include Abhay Agrawal (Q-Line Biotech Limited), Abhishek Mishra (Q-Line Biotech Limited), Ajay Kumar Mahanty (Q-Line Biotech Limited), Akhand Pratap Singh (Q-Line Biotech Limited), Ayush Garg (Q-Line Biotech Limited), Jai Prakash Singh (Q-Line Biotech Limited), among others.